Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, preve...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|
| _version_ | 1826307900200452096 |
|---|---|
| author | Dockrell, HM McShane, H |
| author_facet | Dockrell, HM McShane, H |
| author_sort | Dockrell, HM |
| collection | OXFORD |
| description | The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, prevent disease, or accelerate TB treatment. These vaccines are of different types, and designed to replace BCG, or to boost immunity following BCG vaccination. This viewpoint discusses why, when it has been possible to develop new vaccines for SARS-CoV-2 so quickly, it is taking so long to develop new tuberculosis vaccines. |
| first_indexed | 2024-03-07T07:09:57Z |
| format | Journal article |
| id | oxford-uuid:e7493475-6bf5-491d-8ec6-71679a8e6889 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:09:57Z |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:e7493475-6bf5-491d-8ec6-71679a8e68892022-06-10T06:56:57ZTuberculosis vaccines in the era of Covid-19 - what is taking us so long?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e7493475-6bf5-491d-8ec6-71679a8e6889EnglishSymplectic ElementsElsevier2022Dockrell, HMMcShane, HThe Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines, although there much active research and a vaccine development pipeline, with vaccines designed to prevent infection, prevent disease, or accelerate TB treatment. These vaccines are of different types, and designed to replace BCG, or to boost immunity following BCG vaccination. This viewpoint discusses why, when it has been possible to develop new vaccines for SARS-CoV-2 so quickly, it is taking so long to develop new tuberculosis vaccines. |
| spellingShingle | Dockrell, HM McShane, H Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title | Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title_full | Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title_fullStr | Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title_full_unstemmed | Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title_short | Tuberculosis vaccines in the era of Covid-19 - what is taking us so long? |
| title_sort | tuberculosis vaccines in the era of covid 19 what is taking us so long |
| work_keys_str_mv | AT dockrellhm tuberculosisvaccinesintheeraofcovid19whatistakingussolong AT mcshaneh tuberculosisvaccinesintheeraofcovid19whatistakingussolong |